Navigation Links
Two Preemie Treatments May Not Help
Date:10/29/2008

Insulin, light therapy show disappointing results for the smallest babies, studies show,,,,

WEDNESDAY, Oct. 29 (HealthDay News) -- Two therapies that looked as if they might help prevent serious complications and deaths in the smallest preterm infants have instead yielded disappointing results, studies show.

The studies -- one that examined insulin therapy and one that looked at the effects of aggressive phototherapy -- found that neither treatment was effective in reducing the risk of death, and there was even a slight increase in the death rate for the insulin treatment group. The aggressive phototherapy (light) study, however, did find a lower risk of neurodevelopmental impairments in preemie babies.

Results of both studies were published in the Oct. 30 issue of the New England Journal of Medicine.

More than 12 percent of babies in the United States are born prematurely (before 37 weeks' gestation), according to the March of Dimes, and that number has risen 30 percent since 1981. Babies born early face a host of serious medical problems, and the less developed they are at birth, generally the more problems they face.

One problem that very low birth weight babies often face is high blood glucose levels (hyperglycemia). This can lead to brain hemorrhage, and it also increases the risk of infection, explained Dr. David Dunger, senior author of the insulin study, and a professor of pediatrics at the University of Cambridge in the United Kingdom.

For adults in intensive care, controlling high glucose levels leads to better outcomes, and so, the scientists theorized that the same might hold true for infants.

The current study included 389 babies from multiple medical centers. Half of the infants were given continuous insulin infusions along with continuous dextrose [sugar] support, and the other half received standard care.

"The insulin treatment was effective in lowering glucose levels and allowing more carbohydrate to be given to the babies, resulting in less weight loss," Dunger said. "However, the treatment had no effect on morbidity or mortality and was associated with an increased risk for low blood sugars."

Additionally, editorial author Dr. Richard Polin, from the College of Physicians at Surgeons at Columbia University in New York City, pointed out that "there was an unexpected finding of increased mortality [among those given insulin]."

The bottom line: "This is a special population -- the smallest, sickest premature babies -- but routine use of insulin is not indicated at this time," according to Polin.

Dunger agreed, but added that severe high blood sugar levels still need to be treated.

The second study looked at a more aggressive form of a commonly used treatment called phototherapy. This light therapy is commonly used to treat babies who are born slightly jaundiced, which means that their level of bilirubin -- a substance secreted by the liver -- is elevated. Babies with jaundice appear yellow-tinged.

In premature babies, bilirubin levels may be elevated, and the current study sought to evaluate whether aggressive phototherapy -- meaning a stronger use of light -- would improve neurodevelopmental or illness outcomes in extremely low birth weight infants.

The study included almost 2,000 babies between 12 hours and 36 hours old. Half were assigned to aggressive phototherapy, while the other half received standard phototherapy.

When the researchers looked at death rates and neurodevelopmental impairments together, they found no significant differences between the groups. The death rate was slightly elevated in the aggressive phototherapy group but didn't reach statistical significance.

"In the smallest babies, we were concerned that there was a trend toward an increase in the rate of death," said the study's lead author, Dr. Brenda Morris, who was an associate professor of pediatrics at the University of Texas Medical Center at Houston at the time of the study.

When the researchers looked at neurodevelopmental outcomes alone, they found a 14 percent decreased risk of neurodevelopmental impairment in the group that received the more aggressive therapy. After the initial analysis, the researchers also looked at the rates of profound impairment and found that those babies who received aggressive therapy were 32 percent less likely to have profound impairments.

"I think [the decision of whether or not to use aggressive phototherapy] will be up to individual clinicians who may have to sit and talk with parents about weighing the risks and benefits. In larger babies, it looks like this may be the preferred type of treatment, but in the really small babies, it's going to be an individual decision, probably in conjunction with the parents," said Morris.

More information

Learn more about preterm birth from the March of Dimes.



SOURCES: Brenda Morris, M.D., associate professor of pediatrics, and medical director, neonatal intensive care unit, Trinity Mother Frances Hospital, Tyler, Texas; Richard A. Polin, M.D., professor of pediatrics, College of Physicians and Surgeons, Columbia University, and director of neonatology, Morgan Stanley Children's Hospital, New York City; David Dunger, M.D., professor of pediatrics, University of Cambridge, United Kingdom; Oct. 30, 2008, New England Journal of Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Steroid treatment offers no benefit in preemies, Hopkins Childrens study suggests
2. Alzheimers Drug May Reduce Preemie Brain Injury
3. C-Sections Explain Jump in U.S. Preemie Births
4. Gestational Age Not Sole Predictor of Preemie Survival
5. Neonatologists and pediatricians highlight progress and barriers to preemie care
6. Neonatologists and Pediatricians Highlight Progress and Barriers to Preemie Care
7. Epsom Salt Cut Cerebral Palsy Rate in Half Among Preemies
8. Tel Aviv University gives preemies a fighting chance
9. Caffeine Therapy Boosts Preemies Outcomes
10. Moms Low Cholesterol Tied to Preemie Births
11. Top Indian Cancer Hospital to Introduce Advanced Radiosurgery Treatments With Novalis Tx from Varian Medical Systems and BrainLAB
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two Preemie Treatments May Not Help
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
(Date:6/23/2016)... June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations ... Latin America . ... ... ... ...
Breaking Medicine Technology: